Provided are an electrocardiogram signal parallel analysis apparatus, a mobile terminal incorporating the apparatus, and related methods. The apparatus includes an integrated memory, a central processing unit and a graphic processing unit. The integrated memory includes a first memory and a second memory for being used by the central processing unit and the graphic processing unit respectively, and the central processing unit may access the second memory. The central processing unit performs primary noise reduction on a received electrocardiogram original signal to obtain a primary electrocardiogram signal, and performs abnormal heartbeat classification preliminary screening on characteristic data extracted from the graphic processing unit to obtain suspected abnormal heartbeat data. The graphic processing unit performs characteristic extraction on the primary electrocardiogram signal to obtain characteristic data, performs secondary noise reduction on the primary electrocardiogram signal to obtain a secondary electrocardiogram signal, and processes the suspected abnormal heartbeat data and the secondary electrocardiogram signal by applying a template matching classification mode to obtain final abnormal heartbeat data.

An ambulatory medical device is provided. The ambulatory medical device includes at least one sensor configured to acquire physiological data of a patient, at least one network interface and at least one processor coupled to the at least one sensor and the at least one network interface. The at least one processor is configured to detect, via the at least one network interface, a medical device, to establish a secure communication session with the medical device via the at least one network interface, to detect a data capacity of the secure communication session, to identify a category of patient data associated with the data capacity, and to transmit patient data of the category to the medical device via the secure communication session.

A system for determining electrophysiological data comprising an electronic control unit configured to acquire electrophysiology signals from a plurality of electrodes (130) of one or more catheters, select at least one clique of electrodes from the plurality of electrodes (136) to determine a plurality of local E field data points, determine the location and orientation of the plurality of electrodes, process the electrophysiology signals from the at least one clique from a full set of bipole subcliques to derive the local E field data points associated with the at least one clique of electrodes, derive at least one orientation independent signal from the at least one clique of electrodes (138) from the information content corresponding to weighted parts of electrogram signals, and display or output catheter orientation independent electrophysiologic information to a user or process.

A method and apparatus for treatment of hypertension and heart failure by increasing vagal tone and secretion of endogenous atrial hormones by excitory pacing of the heart atria. Atrial pacing is done during the ventricular refractory period resulting in atrial contraction against closed AV valves, and atrial contraction rate that is higher than the ventricular contraction rate. Pacing results in the increased atrial wall stress. An implantable device is used to monitor ECG and pace the atria in a nonphysiologic manner.

A method, including acquiring initial signals from selected positions in a heart, computing respective initial local values of a signal propagation metric at the selected positions, and interpolating the initial local values between the selected positions to compute initial interpolated values of the signal propagation metric at intermediate positions, between the selected positions. The method further includes acquiring subsequent signals from the positions, computing respective subsequent local values of the signal propagation metric at the selected positions, and spatially interpolating the subsequent local values of the signal propagation metric between the selected positions to compute subsequent interpolated values of the signal propagation metric at the intermediate positions. A map of the signal propagation metric is displayed, and when the subsequent interpolated values exceed a bound defined with respect to the initial interpolated values, an indication is provided on the map that the bound has been exceeded.

A wearable medical treatment device for monitoring a patient's ECG and treating a cardiac condition is disclosed. The device includes a patient vest portion having cardiac sensing electrodes to obtain an ECG signal of a patient, therapy electrodes for external placement proximate to skin of the patient for delivering electrotherapy to treat the cardiac condition, and, a monitor coupled to the cardiac sensing electrodes and the therapy electrodes via at least one cable. The monitor includes a system computer disposed in the monitor. The system computer is configured to receive the ECG signals of the patient and to execute at least one arrhythmia detection algorithm to determine whether the patient is experiencing a cardiac condition in need of treatment, and a mechanical shock detector disposed on the monitor and configured to detect at least one of a force or acceleration indicative of a mechanical shock to the monitor.

A handheld device measures all vital signs and some hemodynamic parameters from the human body and transmits measured information wirelessly to a web-based system, where the information can be analyzed by a clinician to help diagnose a patient. The system utilizes our discovery that bio-impedance signals used to determine vital signs and hemodynamic parameters can be measured over a conduction pathway extending from the patient's wrist to a location on their thoracic cavity, e.g. their chest or navel. The device's form factor can include re-usable electrode materials to reduce costs. Measurements made by the handheld device, which use the belly button as a fiducial marker, facilitate consistent, daily measurements, thereby reducing positioning errors that reduce accuracy of standard impedance measurements. In this and other ways, the handheld device provides an effective tool for characterizing patients with chronic diseases, such as heart failure, renal disease, and hypertension.

Long-term electrocardiographic and physiological monitoring over a period lasting up to several years in duration can be provided through a continuously-recording subcutaneous insertable cardiac monitor (ICM). The sensing circuitry and the physical layout of the electrodes are specifically optimized to capture electrical signals from the propagation of low amplitude, relatively low frequency content cardiac action potentials, particularly the P-waves that are generated during atrial activation. In general, the ICM is intended to be implanted centrally and positioned axially and slightly to either the left or right of the sternal midline in the parasternal region of the chest. Additionally, the ICM includes an ECG sensing circuit that measures raw cutaneous electrical signals and performs signal processing prior to outputting the processed signals for sampling and storage.

Long-term electrocardiographic and physiological monitoring over a period lasting up to several years in duration can be provided through a continuously-recording subcutaneous insertable cardiac monitor (ICM). The sensing circuitry and the physical layout of the electrodes are specifically optimized to capture electrical signals from the propagation of low amplitude, relatively low frequency content cardiac action potentials, particularly the P-waves that are generated during atrial activation. The ICM is intended to be implanted centrally and positioned axially and slightly to either the left or right of the sternal midline in the parasternal region of the chest, with at least one of the ECG sensing electrodes of the ICM being disposed for being positioned in a region overlying the sternum or adjacent to the sternum and the other of the electrodes also being disposed for being positioned over the sternum or adjacent to the sternum of on the patient's chest.

A system and method for facilitating a cardiac rhythm disorder diagnosis with the aid of a digital computer is provided. A plurality of R-wave peaks are identified in a set of ECG data and a difference between recording times of successive pairs of the R-wave peaks are calculated as R-R intervals. A heart rate associated with each time difference is determined. An R-R interval plot of the ECG data is formed. The R-R intervals are plotted along an x-axis of the R-R interval plot and the heart rates associated with the R-R intervals are plotted along a y-axis of the R-R interval plot. A diagnostic composite plot is generated, including the R-R interval plot, a near field view of a portion of the ECG data, and an intermediate field view of a different portion of the ECG data for diagnosis of a cardiac event.